Nearly three years after the FDA approved Pfizer's bispecific antibody Elrexfio as a late-line treatment for patients with ...

A prespecified interim analysis showed statistically significant PFS improvement with elranatamab versus ...

Single agent duvelisib demonstrated clinically meaningful response rates, including a substantial proportion of complete responses, in a heavily ...

Presentation will showcase recent data from multiple clinical studies evaluating dual-targeting CD19/BCMA CAR-T therapy candidate ...

Cancer refers to the appearance, proliferation and invasion of malignant cells into surrounding normal tissue, and oftentimes to other distant sites of the body. They are characterized by their ...

Daratumumab produced rapid and sustained platelet responses in adults with immune thrombocytopenia (ITP), according to a recent single-center, open-label, phase 2 clinical trial (NCT05562882). Despite ...

Refractory multiple myeloma is defined as myeloma cancer that either does not respond to initial treatment or stops responding to it. Common symptoms of refractory multiple myeloma can be remembered ...

Refractory metals are a class of metallic materials that offer superior heat resistance and very high melting points. While the exact definition of which elements are included in this group varies, ...